A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

Author:
  • TIThe Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators
    The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators

Abstract
Thrombin has a pivotal role in the pathogenesis of acute coronary thrombosis. We compared the clinical efficacy of a potent, direct thrombin inhibitor, recombinant hirudin, with that of heparin (an indirect antithrombin agent) in patients with unstable angina or acute myocardial infarction.

This publication has 22 references indexed in Scilit: